Literature DB >> 34849005

Association Between the Cardiometabolic Index and Hyperuricemia in an Asymptomatic Population with Normal Body Mass Index.

Yu-Qiang Zuo1, Zhi-Hong Gao1, Yu-Ling Yin1, Xu Yang1, Ping-Yong Feng2.   

Abstract

BACKGROUND AND
PURPOSE: The association between the cardiometabolic index (CMI) and hyperuricemia was investigated to provide theoretical support for the management of hyperuricemia in an asymptomatic population with normal body mass index (BMI).
METHODS: A cross-sectional study was carried out among 374 asymptomatic adults with normal BMI. Traditional anthropometric indices and CMI were calculated. Anthropometric indices were divided into four quartiles and multivariate logistic analysis was used to analyze the association between these indices and hyperuricemia. Receiver operating characteristic (ROC) curves and area under the curve (AUC) were used to evaluate the power of the indices to predict hyperuricemia values. The DeLong test was used to compare the AUC of different anthropometric indices.
RESULTS: After adjusting for confounding variables, the CMI exhibited a stronger association with hyperuricemia than other anthropometric indices. The odds ratio (OR) for hyperuricemia in the highest quartile of the CMI was 16.674 (confidence interval [CI]=4.424-62.846). The AUC of the CMI was 0.777 (95% CI=0.719-0.835, p<0.001), which was higher than the values for other anthropometric indices. The differences in AUC between the CMI and other indices were statistically significant; the optimal cutoff value of the CMI was 0.655, with sensitivity of 57.1% and specificity of 84.2%.
CONCLUSION: The CMI, which combines waist circumference, height and blood lipid parameters, was more strongly associated with hyperuricemia than other anthropometric indices in asymptomatic population with normal BMI. The CMI may serve as a potential monitoring indicator for hyperuricemia management in asymptomatic populations with normal BMI.
© 2021 Zuo et al.

Entities:  

Keywords:  cardiometabolic index; hyperuricemia; lipid accumulation product; visceral adiposity index

Year:  2021        PMID: 34849005      PMCID: PMC8627282          DOI: 10.2147/IJGM.S340595

Source DB:  PubMed          Journal:  Int J Gen Med        ISSN: 1178-7074


  43 in total

Review 1.  Insulin resistance: Review of the underlying molecular mechanisms.

Authors:  Habib Yaribeygi; Farin Rashid Farrokhi; Alexandra E Butler; Amirhossein Sahebkar
Journal:  J Cell Physiol       Date:  2018-10-14       Impact factor: 6.384

Review 2.  Pathogenesis of Lipid Disorders in Insulin Resistance: a Brief Review.

Authors:  Petter Bjornstad; Robert H Eckel
Journal:  Curr Diab Rep       Date:  2018-10-17       Impact factor: 4.810

3.  Effect of insulin on renal sodium and uric acid handling in essential hypertension.

Authors:  E Muscelli; A Natali; S Bianchi; R Bigazzi; A Q Galvan; A M Sironi; S Frascerra; D Ciociaro; E Ferrannini
Journal:  Am J Hypertens       Date:  1996-08       Impact factor: 2.689

4.  Low HDL cholesterol as a predictor of chronic kidney disease progression: a cross-classification approach and matched cohort analysis.

Authors:  Keiko Kawachi; Hiroshi Kataoka; Shun Manabe; Toshio Mochizuki; Kosaku Nitta
Journal:  Heart Vessels       Date:  2019-03-14       Impact factor: 2.037

5.  Gender-related differences in serum uric acid in treated hypertensive patients from central and east European countries: findings from the Blood Pressure control rate and CArdiovascular Risk profilE study.

Authors:  Pau Redon; Alessandro Maloberti; Rita Facchetti; Josep Redon; Empar Lurbe; Michele Bombelli; Giuseppe Mancia; Guido Grassi
Journal:  J Hypertens       Date:  2019-02       Impact factor: 4.844

6.  The Impact of Blood Pressure and Visceral Adiposity on the Association of Serum Uric Acid With Albuminuria in Adults Without Full Metabolic Syndrome.

Authors:  Alena Krajcoviechova; Johanne Tremblay; Peter Wohlfahrt; Jan Bruthans; Muhmmad Ramzan Tahir; Pavel Hamet; Renata Cifkova
Journal:  Am J Hypertens       Date:  2016-12-01       Impact factor: 2.689

7.  Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk.

Authors:  Marco C Amato; Carla Giordano; Massimo Galia; Angela Criscimanna; Salvatore Vitabile; Massimo Midiri; Aldo Galluzzo
Journal:  Diabetes Care       Date:  2010-01-12       Impact factor: 17.152

8.  Effectiveness of body roundness index in predicting metabolic syndrome: A systematic review and meta-analysis.

Authors:  Sergio Rico-Martín; Julían F Calderón-García; Purificación Sánchez-Rey; Cristina Franco-Antonio; Mariana Martínez Alvarez; Juan F Sánchez Muñoz-Torrero
Journal:  Obes Rev       Date:  2020-04-08       Impact factor: 9.213

9.  Visceral adiposity index is strongly associated with hyperuricemia independently of metabolic health and obesity phenotypes.

Authors:  Huimin Dong; Yang Xu; Xiuzhi Zhang; Simiao Tian
Journal:  Sci Rep       Date:  2017-08-18       Impact factor: 4.379

10.  The etiology of oxidative stress in insulin resistance.

Authors:  Samantha Hurrle; Walter H Hsu
Journal:  Biomed J       Date:  2017-11-08       Impact factor: 4.910

View more
  2 in total

1.  Triglyceride Glucose Index Is More Closely Related to Hyperuricemia Than Obesity Indices in the Medical Checkup Population in Xinjiang, China.

Authors:  Mayina Kahaer; Bei Zhang; Wujin Chen; Meiting Liang; Yi He; Miao Chen; Rui Li; Tingting Tian; Cheng Hu; Yuping Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-02       Impact factor: 5.555

2.  Associations of the Cardiometabolic Index with the Risk of Cardiovascular Disease in Patients with Hypertension and Obstructive Sleep Apnea: Results of a Longitudinal Cohort Study.

Authors:  Xintian Cai; Junli Hu; Wen Wen; Jingyu Wang; Mengru Wang; Shasha Liu; Qing Zhu; Jing Hong; Yujie Dang; Xiaoguang Yao; Le Sun; Delian Zhang; Qin Luo; Nanfang Li
Journal:  Oxid Med Cell Longev       Date:  2022-06-23       Impact factor: 7.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.